Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment